Literature DB >> 12094429

[Hepatic encephalopathy].

D Häussinger1, G Kircheis.   

Abstract

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome which develops during chronic or acute liver disease. It is functional in nature and potentially reversible and symptoms range from subtle personality changes to deep coma. Diagnosis of manifest HE is made on a clinical basis, whereas psychometric tests are required to diagnose subclinical HE (SHE). Paper-pencil tests are frequently used for diagnosing SHE, but they may be inferior to measurements of critical flicker frequency, which pick minimal and low grade manifest HE as a continuum. Pathogenetically, HE is seen as clinical manifestation of low grade chronic cerebral edema, which is accompanied by alterations in glioneuronal communication. Different factors such as ammonia, inflammatory cytokines, benzodiazepines and electrolyte imbalances may precipitate or aggravate glia edema, thereby explaining precipitation of HE episodes by a variety of unrelated factors. Recognition and rigorous treatment of these precipitating factors is the most important measure in HE therapy, which may be augmented by dietary and medical approaches.

Entities:  

Mesh:

Year:  2002        PMID: 12094429     DOI: 10.1024/0369-8394.91.22.957

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  4 in total

1.  Relationship between encephalopathy and portal vein-vena cava shunt: value of computed tomography during arterial portography.

Authors:  Qian Chu; Zhen Li; Su-Ming Zhang; Dao-Yu Hu; Ming Xiao
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

2.  Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.

Authors:  Josef Finsterer; Elisabeth Bernauer
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

3.  Hepatic Encephalopathy in Patients in Lviv (Ukraine).

Authors:  Herbert Djiambou-Nganjeu
Journal:  J Transl Int Med       Date:  2018-10-09

4.  Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy.

Authors:  Hiroyuki Nakanishi; Yuka Hayakawa; Youhei Kubota; Masayuki Kurosaki; Leona Osawa; Kento Inada; Sakura Kirino; Koji Yamashita; Shuhei Sekiguchi; Mao Okada; Wang Wan; Mayu Higuchi; Kenta Takaura; Chiaki Maeyashiki; Shun Kaneko; Nobuharu Tamaki; Yutaka Yasui; Takamasa Noda; Kaoru Nakanishi; Kaoru Tsuchiya; Jun Itakura; Yuka Takahashi; Namiki Izumi
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.